The Evidence Based Rheumatology Podcast

E115: Benralizumab for EGPA - the MANDARA Study


Episode Artwork
1.0x
0% played 00:00 00:00
Oct 28 2024 9 mins   12
Other Episodes

Quick rundown of an important rheumatology RCT this week, discussing the IL-5 inhibitor benralizumab for the treatment of relapsing/refractory EGPA.



MANDARA Study: https://www.nejm.org/doi/full/10.1056/NEJMoa2311155

Download episode Share
Copy URL



Listen on Podcast Addict
Subscribe on Podcast Addict